Physician profile
Candyse Elizabeth Brewer
NPI 1588263495
$3,553.03
in general payments reported to CMS, 2019-2025
27 companies · $1,039 in 2025
The $1,039 reported for 2025 was more than what 84% of Gerontology (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $161).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $720 · 2023: $983 · 2024: $812 · 2025: $1,039.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,822 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,822.30 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $504.26 | 2022-2025 | Wainua, Farxiga, Brilinta |
| Amgen INC. | $452.95 | 2022-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $415.42 | 2022-2025 | Verquvo, Winrevair |
| Abbott Laboratories | $351.27 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Pfizer INC. | $281.51 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $265.52 | 2022-2024 | Xarelto |
| Novo Nordisk INC | $240.29 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $137.55 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.69 | 2022-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $125.60 | 2023-2025 | Lifevest |
| Tactile Systems Technology INC | $87.58 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Sanofi-Aventis U.S. LLC | $75.08 | 2022-2023 | |
| Baxter Healthcare | $53.89 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $48.79 | 2022-2025 | Eliquis, Camzyos |
| Esperion Therapeutics, INC. | $46.46 | 2022-2025 | Nexletol |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $41.29 | 2025 | Extended Holter |
| Alnylam Pharmaceuticals INC. | $40.42 | 2023 | Onpattro |
| Glaxosmithkline, LLC. | $38.22 | 2025 | Arexvy, Shingrix |
| Kiniksa Pharmaceuticals, Ltd. | $32.96 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.76 | 2022 | |
| Bridgebio Pharma, INC. | $29.24 | 2025 | Attruby |
| Irhythm Technologies, INC. | $29.19 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $27.62 | 2024 | Arcalyst |
| Chiesi USA, INC. | $17.59 | 2024 | Cleviprex, Kengreal |
| Lilly USA, LLC | $17.23 | 2025 | Mounjaro, Zepbound |
| Dexcom, INC. | $15.42 | 2023 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $15.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candyse Brewer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.